Abstract:Autophagy fundamentally refers to a process where cells enclose their own cell organelles with isolated membrane and deliver them to lysosomes for degradation, servicing as a nonspecific degradation mechanism of autologous proteins. Autophagy is induced above basal levels in response to nutrient deprivation or trophic factor withdrawal to sustain metabolism by producing catabolites. In this context, autophagy acts as a cytoprotective mechanism for cells to protect themselves from extracellular stresses. However, in a culture using cells in which autophagy-related genes were suppressed by siRNA and to which an autophagy inhibitor, 3- methyladenine (3-MA), was added, cytotoxic effects of some anticancer agents on cancer cells were diminished. Based on these results, the concept of caspase-independent cell death via autophagy, which is designated as type II programmed cell death (PCD) in contrast to apoptosis as type I PCD, has been receiving increased attention. We here report that treatment of AML cells with low does-Ara-C induces autophagy and enhances its cytocidal effect on AML cells by combined treatment with G-CSF. Treatment of AML cell line U937 cells with 1 to 50 ng/ml of Ara-C induced cell growth inhibition in a dose-dependent manner. Exposure to the higher concentrations of Ara-C (more than 10 ng/ml) induced apoptosis in U937 cells along with formation of apoptotic bodies and caspase-3 activation. However, treatment with the lower concentration of Ara-C (2.5 to 7.5 ng/ml) induced autophagy as assessed by electron microcopy and the punctuated distribution pattern of cytoplasmic microtubule-associated protein 1 light chain 3B (LC3B) by fluorescent immunocytochemistry. Low dose-Ara-C inducing -cell death and -autophagy both were suppressed when the cells were cultured in the presence of 3-MA. This suggests that the autophagic cell death but not the cytoprotective autophagy was induced in response to Ara-C. Combined treatment with G-CSF (lenograstim; 100 ng/ml) plus 2.5 to 7.5 ng/ml of Ara-C, but not plus higher concentrations of Ara-C, resulted in the enhanced cytocidal effect in U937 cells in vitro. These data indicate that combined treatment of Ara-C plus G-CSF has a therapeutic benefit for the AML patients by enhanced cytocidal effect which appears to be mediated via induction of autophagy. In addition, our data appear to explain in part the high response rate of CAG therapy in refractory AML, which consists of low-dose Ara-C in combination with G-CSF and aclarubicin.

A study on the gene expression of telomerase subunits and the cell apoptosis and necrosis in U937 cells induced by cytarabine

The Changes of Mrna Expression of Telomerase Subunits Induced by Ara-C in HL-60 Cells

[Study on the Mechanisms of Telomerase Regulations During Apoptosis of the Human MDS-RAEB Cell Line MUTZ-1 Cells Induced by Arsenic Trioxide].

Interferon-α in Combination with Homoharringtonine Induces K562 Cell Apoptosis Through Down-Regulating Human Telomerase Reverse Transcriptase Expression and Telomerase Activity

Cerulenin Changes Apoptosis Related Genes Expression in Multiple Myeloma Cell Line U266

The expression of cell membrane transporter-human equilibrative nucleoside transporter 1 in leukemia cell lines treated with Ara-C

The Effects of Adramycin on Telomerase Activity and Expression of Telomere Repeat Binding Factor Proteins in Tca8113 Cells

Autophagy Induction of Acute Myeloid Leukemia (aml) Cells after Treatment with Low Dose-Cytarabine (Ara-C) and Enhanced Cytocidal Effect on Aml Cells by Combined Treatment with Ara-C Plus Lenograstim.

[Effect of Bortezomib and Low Concentration Cytarabine on Apoptosis in U937 Cell Line].

Study on mechanism of apoptosis induced by Ara-C in leukemia HL-60 cells

Effect of Tanshinone IIA on Expression of Human Telomerase Reverse Transcriptase in HL -60 Cells

[Effects of Apoptosis of Tca8113 Cells Induced by Adriamycin on Telomerase and Telomere Repeat Binding Factor Proteins].

Different Ways of Combination of Tretinoin with Cytarabine or Daunorubicin Lead to Variable Change of HL-60's Apoptosis in Vitro

In Vitro Investigation of Effect of CAG Regimen on U937 Cell Line

Effects of Ara-C on proliferation/apoptosis and bcl-2 gene expression of HL60 cell

[Human umbilical cord mesenchymal stem cells reduce the sensitivity of HL-60 cells to cytarabine]

Autophagy is an Important Event for Low-Dose Cytarabine Treatment in Acute Myeloid Leukemia Cells

Coupled Down-Regulation of Mtor and Telomerase Activity During Fluorouracil-Induced Apoptosis of Hepatocarcinoma Cells

Study on the Mechanism of CAG Treatment to U937 Cell

Effect of small interfering RNA directed against telomerase on the proliferation and apoptosis of Hut78 cells

The synergistic effect of miR-203 and cytarabine on the inhibition of cell proliferation and induction of apoptosis in chronic myelogenous leukemia cells